Continued afatinib (A) with the addition of cetuximab (C) after progression on afatinib in patients with acquired resistance (AR) to gefitinib (G) or erlotinib (E) Meeting Abstract


Authors: Horn, L.; Gettinger, S.; Camidge, R.; Smit, E.; Janjigian, Y.; Pao, W.; Schnell, D.; Wang, B.; Chand, V.; Groen, H.
Abstract Title: Continued afatinib (A) with the addition of cetuximab (C) after progression on afatinib in patients with acquired resistance (AR) to gefitinib (G) or erlotinib (E)
Meeting Title: 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 90
Issue: 5 Suppl.
Meeting Dates: 2014 Oct 30-Nov 1
Meeting Location: Chicago, IL
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2014-11-15
Start Page: S39
End Page: S40
Language: English
ACCESSION: WOS:000346413500083
PROVIDER: wos
DOI: 10.1016/j.ijrobp.2014.08.220
Notes: Meeting Abstract: 181 -- Chicago Multidisciplinary Symposium in Thoracic Oncology -- OCT 30-NOV 01, 2014 -- Chicago, IL -- 5 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yelena Yuriy Janjigian
    394 Janjigian